Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies
Tyulyandina, Alexandra, Harrison, Daniel, Yin, Wei, Stepanova, Evgenia, Kochenkov, Dmitry, Solomko, Eliso, Peretolchina, Nina, Daeyaert, Frits, Joos, Jean-Baptiste, Van Aken, Koen, Byakhov, Mikhail, GVolume:
35
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-016-0404-1
Date:
April, 2017
File:
PDF, 3.82 MB
english, 2017